Comparing Neulasta vs Udenyca
| Neulasta (pegfilgrastim) | Udenyca (pegfilgrastim) |
|
|---|
| Neulasta (pegfilgrastim) | Udenyca (pegfilgrastim) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Neulasta injection is a prescription medicine that may be given once every chemotherapy cycle to prevent febrile neutropenia in those people at high risk of it because of cancer treatments they are... View more |
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia Associated with Radiation, Febrile Neutropenia, Hematopoietic Syndrome of Acute Radiation Syndrome. Udenyca may also be used for... View more |
Related suggestions Neutropenia Associated with Chemotherapy
Febrile Neutropenia
Hematopoietic Syndrome of Acute Radiation Syndrome
Neutropenia Associated with Radiation
Popular comparisons
|
|||||||||||||||
| More about Neulasta (pegfilgrastim) | More about Udenyca (pegfilgrastim) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Neulasta has an average rating of 5.1 out of 10 from a total of 71 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 45% reported a negative effect. |
Udenyca has an average rating of 1.0 out of 10 from a total of 3 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Neulasta side effects |
View all Udenyca side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Neulasta prices |
View all Udenyca prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other pegfilgrastim brands include: Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo | Other pegfilgrastim brands include: Fulphila, Fylnetra, Neulasta, Nyvepria, Stimufend, Ziextenzo | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
80 hours |
80 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 178 drugs are known to interact with Neulasta:
|
A total of 178 drugs are known to interact with Udenyca:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
January 31, 2002 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.